Covid vaccine will be available for all by December: JP Nadda
India | May 20, 2021 15:55 ISTBJP president JP Nadda said that coronavirus vaccine will be available for all in the country by December.
BJP president JP Nadda said that coronavirus vaccine will be available for all in the country by December.
Government said on Tuesday trials on Covaxin’s efficacy against coronavirus on children between 2-18 years of age to begin in 10-12 days.
India saw a record 4,529 fatalities due to coronavirus in a single day pushing the COVID-19 death toll to 2,83,248, while 2.67 lakh fresh cases were recorded.
The B.1.617 virus variant, first identified in India last year, has been classified as a 'variant of concern' at the global level by the World Health Organisation.
Multinational pharma giant Johnson and Johnson along with Telangana-based Biological E. Limited will manufacture the Johnson & Johnson COVID-19 vaccine, which could boost the country's overall supplies amid a shortage.
Delhi on Tuesday received over 60,000 Covaxin doses for key workers and those aged above 45, AAP MLA Atishi said.
According to the scientist, vaccine doses will be safe no matter when they are taken but will not provide any great "boosting" if given within less than a month or so of the previous dose.
BJP spokesperson Sambit Patra said that the Congress toolkit highlights how the party wants to strengthen itself using the pandemic.
Chief minister Yogi Adityanath has said that about 1.3 lakh such centres across the state will assist people in registering on the app and eventually, provide the facility of vaccination.
The United States will share 20 million more COVID-19 vaccine doses with other countries, taking the total number of such shots to 80 million.
Haryana on Monday reported 114 COVID deaths and 7,488 fresh cases, taking the state’s fatality count to 6,799 and the total infection number to 7,01,915, according to a Health Department bulletin.
The World Health Organization (WHO) has classified the coronavirus variant first found in India as a "variant of global concern".It said studies show the B.1.617 mutation spreads more easily than other variants and requires further study.
The cumulative number of COVID-19 vaccine doses administered in the country has crossed 18.44 crore with 14,79,592 doses given on Monday, the Union Health Ministry said.
Bharat Biotech's Covaxin manufacturing facility is under construction in Kolar district of Karnataka.
Saudi travellers are required to show their health statuses to airport officials through the government's health app, Tawakkalna. Travellers returning from abroad will be required to quarantine at home and be tested for the virus.
Telangana, which claims to have the capacity to give 10 lakh vaccines every day, is administering 30,000 to 40,000 vaccines daily due to the shortage. On May 14, the health authorities administered about 34,000 vaccines.
The Union health ministry on Sunday clarified that already booked online appointments for second dose of Covishield vaccine will remain valid and the same will not be cancelled on Co-WIN platform.
Hester Biosciences on Sunday said it has tied up with the Gujarat government to explore production of COVID-19 vaccine through technology transfer from Bharat Biotech. The Ahmedabad-based firm said it has already initiated the discussions with Bharat Biotech in this regard.
More than 1.84 crore COVID-19 vaccine doses are still available with states and UTs, while nearly 51 lakh doses are in the pipeline and will be received by them within the next three days, the Union Health Ministry said on Sunday.
As per an infographic, a modest reduction in neutralisation by a factor of 1.95 was observed against the B.1.617 variant compared to the vaccine variant (D614G).
Top News
Latest News
